Form 4: 10x Genomics President and CSO Sells Shares to Cover Tax Obligations

Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, Inc., sold 7,485 shares of Class A Common Stock to satisfy tax withholding obligations related to restricted stock unit vesting.

Summary

• Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics, Inc. (TXG), reported a sale of company stock.
• On May 22, 2025, Mr. Hindson sold 7,485 shares of Class A Common Stock.
• The shares were sold at a price of $8.2993 per share, totaling approximately $62,110.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Hindson beneficially owns 448,374 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale of shares by an insider to cover tax obligations related to the vesting of restricted stock units, which is a common practice and generally does not indicate a change in management's outlook or confidence.

Positives

• The sale was non-discretionary, specifically executed to cover tax withholding obligations, which is a standard and common practice for executives receiving equity compensation.

Negatives

• The transaction resulted in a reduction of direct beneficial ownership by an insider, although for a non-discretionary reason.

Future Outlook

NA

Management Comments

• "The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."

Industry Context

NA

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but for a non-discretionary reason, so minimal negative impact.

Key Dates

Keywords

10x Genomics, TXG, SEC Form 4, Insider Trading, Stock Sale, Benjamin J. Hindson, Restricted Stock Units, Tax Withholding, Officer Transaction, Director Transaction